Anecortave

未知生产厂商

Anecortave is under investigation in clinical trial NCT00691717 (Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Anecortave is under investigation in clinical trial NCT00691717 (Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension).

技术标识符

化学式: C₂₁H₂₈O₄
CAS 编号: 10184-70-0
UNII ID: R5Y8O51589

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
US 2007043006 A1申请人: BINGAMAN DAVID P优先权: 2003
US
WO
3 件公开
Triamcinolone acetonide and anecortave acetate formulations for injection
CN 1852700 A申请人: ALCON INC优先权: 2003
CN
US
2 件公开
Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
US 2006166956 A1申请人: JERDAN JANICE A优先权: 2003
US
2 件公开
Formulations of glucocorticoids to treat pathologic ocular angiogenesis
US 2006074061 A1申请人: BINGAMAN DAVID P优先权: 2004
US
2 件公开
Method for treating primary and secondary forms of glaucoma
- CN 101365456 A
  申请人: ALCON INC优先权: 2005
  CN
- US 2007197491 A1
  申请人: ALCON INC优先权: 2006
  US
- US 2008125406 A1
  申请人: ROBIN ALAN L优先权: 2007
  US
Use of anecortave acetate as an adjunct during filtration bleb surgery
CN 101346145 A申请人: ALCON INC优先权: 2005
CN
Combination treatment for pathologic ocular angiogenesis
US 2007134244 A1申请人: ALCON INC优先权: 2006
US

药物

Anecortave

概览

专利

Method for treating primary and secondary forms of glaucoma